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Within the mammalian genome, there are many multimember gene families that encode membrane proteins with extracellular leucine rich repeats
which are thought to act as cell adhesion or signalling molecules.We previously showed that the members of theNLRR gene family are expressed in a
developmentally restricted manner in the mouse with NLRR-1 being expressed in the developing myotome. The FLRT gene family shows a similar
genomic layout and predicted protein secondary structure to the NLRRs so we analysed expression of the three FLRT genes during mouse
development. FLRTs are glycosylated membrane proteins expressed at the cell surface which localise in a homophilic manner to cell–cell contacts
expressing the focal adhesion marker vinculin. Each member of the FLRT family has a distinct, highly regulated expression pattern, as was seen for
the NLRR family. FLRT3 has a provocative expression pattern during somite development being expressed in regions of the somite where muscle
precursor cells migrate from the dermomyotome andmove into the myotome, and later in myotomal precursors destined tomigrate towards their final
destination, for example, those that form the ventral body wall. FLRT3 is also expressed at the midbrain/hindbrain boundary and in the apical
ectodermal ridge, regions where FGF signalling is known to be important, suggesting that the role for FLRT3 in FGF signalling identified in Xenopus
is conserved in mammals. FLRT1 is expressed at brain compartmental boundaries and FLRT2 is expressed in a subset of the sclerotome, adjacent to
the region that forms the syndetome, suggesting that interaction with FGF signalling may be a general property of FLRT proteins. We confirmed this
by showing that all FLRTs can interact with FGFR1 and FLRTs can be induced by the activation of FGF signalling by FGF-2.We conclude that FLRT
proteins act as regulators of FGF signalling, being induced by the signal and then able to interact with the signalling receptor, in many tissues during
mouse embryogenesis. This process may, in part, be dependent on homophilic intercellular interactions between FLRT molecules.
© 2006 Elsevier Inc. All rights reserved.Keywords: Mouse; Somite; Myoblast, Fibronectin leucine rich repeat transmembrane (FLRT); Focal adhesion; FGF signallingIntroduction
Leucine rich repeats (LRRs) are a conserved hydrophobic
repeat structure of approximately 24 amino acids. They are
present in proteins of all organisms and of diverse function that
can be located inside the cell, associated with cell membranes or
in the extracellular space (Kobe and Deisenhofer, 1995).
Advances in the understanding of LRR structure have shown
that the repeated leucine motifs form a structural framework that
provides a concave molecular surface for protein interaction⁎ Corresponding author. Fax: +44 20 7352 0272.
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doi:10.1016/j.ydbio.2006.04.004(Kobe and Kajava, 2001). The protein interaction occurs
through amino acid side chains distributed throughout the
LRR so it is thought they can interact with proteins of diverse
structure. However, relatively little is known about the proteins
that interact with specific LRRs.
Many membrane localised proteins contain leucine rich repeats
in their extracellular regions suggesting that they may be involved
in mediating cell signalling or adhesion through interaction with
surrounding cells, the extracellular matrix or extracellular ligands
(Buchanan and Gay, 1996). These proteins vary in the number of
repeats, the presence of other extracellular domains and their
method of anchorage to themembrane. They often fall intomultiple
member families that have common secondary structures (Musac-
chio and Perrimon, 1996; Lacy et al., 1999; Nagasawa et al., 1999;
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2003; Hamano et al., 2004; Haines et al., 2005) suggesting that they
have undergone evolutionary gene expansion. Many of these
proteins are expressed in the nervous system with several LRR
membrane proteins implicated in axon guidance and cell
movement. In Drosophila homophilic interaction of connectin
molecules is implicated in neuromuscular target recognition (Nose
et al., 1997) and the protein capricious has been implicated in
neuron pathfinding and synapse formation (Shishido et al., 1998;
Taniguchi et al., 2000). The mammalian LRR containing Nogo
receptor performs an important function in axon pathfinding
(Fournier et al., 2001) while AMIGO family members (Kuja-
Panula et al., 2003) and rat FLRT3 (Tsuji et al., 2004) cause
increased neurite outgrowth in cell culture. Homophilic interaction
has been seen between several of these proteins suggesting that they
may provide amechanism for regulating the affinity of like cells for
each other (Nose et al., 1997; Kuja-Panula et al., 2003).
The FLRT gene family was initially identified in a screen for
novel extracellular matrix proteins from a human adult skeletal
muscle library by screening with a degenerate oligonucleotide
(Lacy et al., 1999) designed to the G2 domains of nidogen/entactin.
It was shown to be a three gene family with a conserved predicted
secondary structure consisting of ten leucine-rich repeats sur-
rounded by C-terminal and N-terminal cysteine flanking regions, a
fibronectin like domain, a transmembrane domain and a short
intracellular tail. Their predicted secondary structure, alongwith the
glycosylation of overexpressed FLRT protein, indicates that they
are expressed at the cell surface with the extracellular leucine rich
repeats available for protein–protein interaction suggesting they act
as cell adhesion or signalling molecules. Rat FLRT3 (Tsuji et al.,
2004; Robinson et al., 2005) and Xenopus FLRT3 (XFLRT3)
(Bottcher et al., 2003) have been shown to localise to the cell
surface. In adult mouse tissue all FLRT family members are
expressed in the brain with additional expression for FLRT1 in the
kidney, FLRT2 in the heart, skeletal muscle and pancreas, and
FLRT3 in many tissues (Lacy et al., 1999).XFLRT3 (XFLRT3) was
cloned as a member of a syn-expression group with FGF8 and was
shown to be a modulator of FGF signalling in the Xenopus embryo
(Bottcher et al., 2003). XFLRT3 interacts with the FGFR via its
fibronectin like domain but could mediate FGF signalling via its
intracellular domain indicating its role may involve the recruitment
of intracellular signalling molecules to the cell membrane for the
transduction of extracellular signals into the cell. These data suggest
thatFLRT genes, and other similar gene families,may not simply be
modulators of cell adhesion but have the ability to interact with
other proteins at the cell surface and regulate gene expressionwithin
the cell.
We have recently shown that theNLRR genes, a three member
gene family with similar genomic and predicted protein
structures, have a highly regulated pattern of expression during
mouse development (Haines et al., 2005). In this study, we
analyse the expression of the structurally similar FLRT family of
genes during mouse development. We find that each member of
the three gene FLRT family has a distinct expression pattern
localising to specific cell populations. FLRT1 is expressed in
cells of the dorsal root ganglia, trigeminal ganglia and facio-
acoustic ganglia, the midbrain/hindbrain and forebrain/midbrainboundaries, the eye as well as several other defined tissues.
FLRT2 is expressed in segmental stripes in a subset of the
sclerotome, the cephalic mesoderm, head mesoderm and the
epithelia of the body wall. FLRT3 has a provocative expression
pattern during somite development being expressed in regions of
the somite where muscle precursor cells migrate from the
dermomyotome and move into the myotome and later in
myotomal precursors destined to migrate towards their final
destination. FLRT expression in the midbrain/hindbrain bound-
ary, the apical ectodermal ridge and the developing sclerotome
shows that FLRT expression in tissues known to be regulated by
FGF signalling is conserved between frogs andmice. The FLRTs
are glycosylated membrane proteins expressed efficiently at the
cell surface that have the ability to localise to focal adhesions in a
homophilic manner. They can be induced by the activation of
FGF signalling and can interact with FGF receptors suggesting
that they are involved in the regulation of FGF signalling in
many tissues during development.
Materials and methods
FLRT cDNAs
The IMAGE clone 2236543 contained the entire FLRT1 open reading frame.
cDNAs containing the complete FLRT2 and FLRT3 open reading frames were
amplified from 10.5 dpc mouse embryo RNA using primers designed to mouse
EST sequences identified by BLAST searching with the corresponding human
FLRT sequences. FLRT2, 5′-ATGAGGGCAACCTAGGCAGA and 5′-
TGTTACGTATGGCAATGCTC; FLRT3, 5′-AGTAACAGAAGCTACCTGCT
and 5′-TGAAAAACGGCCTGTGCTTA. N-terminal FLAG tagged constructs
were made by PCR inserting the FLAG tag one amino acid upstream of the first
cysteine residue of the N-terminal cysteine flanking sequence. C-terminal HA
tagged constructs were made by PCR. Expression constructs for mammalian
cells were in pCDNA3.1 (Invitrogen).
Protein sequence alignments were performed using ClustalW and annotated
using Boxshade available at www.ch.embnet.org.
In situ hybridisation
In situ hybridisation was performed as described by Haines et al. (2005)
using the InsituPro in situ hybridisation processor (Intavis AG). Hybridisations
were carried out at 69°C. Embryos were stained with 200 ng/ml Red Phos and
30 ng/ml NBT which gives lower background than BCIP/NBT.
Embryos were sectioned by embedding in agarose and cutting 70 μm
sections using a vibratome. Antisense digoxygenin-labelled riboprobes were
generated using 10× digoxygenin RNA labelling mix and RNA polymerases
(Roche) following the manufacturer's instructions. A probe for FLRT1 was
transcribed from a FLRT1 cDNA contained in the image clone 1107727, in the
vector pBluescribe, by digestion with ScaI and transcription with T7 RNA
polymerase (Roche). A riboprobe for FLRT2 was transcribed using T3
polymerase from a BamHI digest of the plasmid FLRT2 Pst, which was made
by digesting the FLRT2 image clone 553778 with PstI and cloning the 5′ most
fragment into PstI cut pBluescript II KS (Stratagene). A riboprobe for FLRT3
was transcribed using T3 polymerase from a BamHI digest of the plasmid
FLRT3 Age, which was made by digesting the FLRT3 image clone 4950755
with AgeI and cloning the 5′ most fragment into XmaI cut pBluescript II KS.
FLRT protein analysis
For immunofluorescence Cos-7 cells were grown on coverslips and
transfected using Fugene 6 transfection reagent (Roche) following the
manufacturer's instructions. All applications were performed 48 h post-
transfection. For whole cell staining cells were fixed in methanol for 2 min at
− 20°C, rehydrated in PBS for 15 min and stained with a 1 in 500 dilution of anti
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and 3% BSA. Coverslips were washed 3 times for 5 min with PBST and stained
with a 1 in 200 dilution of FITC conjugated anti mouse antibody (Sigma) for
45 min in PBS. Cells were washed 3 times for 5 min in PBST and mounted on
glycerol or Vectastain mounting media (Vectorlabs). For staining of protein at
the cell surface cells were fixed in 4% paraformaldehyde, incubated with 10 mM
glycine and washed gently 3 times with PBS before staining with anti FLAG
antibody. For analysis of protein movement after reaching the cell membrane
cells were incubated with anti-FLAG antibody diluted 1 in 1000 in DMEM:10%
FCS at 37°C for 4 h. Cells were then fixed in methanol, rehydrated and stained
with FITC conjugated anti mouse antibody (1/200) as previously described. To
co-stain for vinculin transfected cells were incubated with anti-FLAG antibody,
fixed with methanol and then incubated with rabbit anti-vinculin antibody
(Santa Cruz) diluted 1/10 in PBS containing 1% BSA. Cells were washed and
stained with anti-mouse Texas red and anti-rabbit FITC secondary antibodies.Fig. 1. The mouse FLRT protein family. (A) Comparison of the amino acid sequen
residues of the C- and N-terminal flanking sequences are highlighted by asterisks. C
Hydrophobic signal and transmembrane sequences are underlined by a dashed line
Schematic representation of the FLRT protein family. SS—signal sequence; NFR—
flanking sequence; FN—fibronectin type III domain; TM—transmembrane domai
between mouse, human and Xenopus FLRT proteins.For Western blot of FLRT proteins Cos-7 cells were plated in 6 cm dishes
and transfected using Fugene 6 transfection reagent. 24 h post-transfection cells
were changed into fresh medium or medium containing 8 μg/ml Tunicamycin
(Sigma) and lysed 48 h post-transfection by resuspension in 100 μl 1× SDS-
PAGE gel loading buffer and heating at 100°C for 10 min. Protein extracts were
separated by SDS-PAGE on a 15% gel and transferred to PVDF membrane
(NEN Life Science). Blots were probed with anti-HA monoclonal antibody
(Covance) following the manufacturer's instructions. Blots were visualised
using ECLWestern blotting detection reagents (Amersham).
FGF signalling analysis
Experiments were performed in the human embryonic kidney (HEK) 293T
cell line. Cells were cultured and transfected as previously described (Burgar et
al., 2002). For FGF2 stimulation, media was replaced with Krebs HEPES Bufferces of the FLRT protein family. Leucine rich repeats are underlined. Cysteine
onserved tryptophan and tyrosine residues of the fibronectin domain are boxed.
. A conserved sequence in the intracellular domain is double underlined. (B)
N-terminal flanking sequence; LRR—leucine rich repeat; CFR—C-terminal
n; IC—conserved intracellular domain. (C) Percentage of amino acid identity
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the presence of 10 μg/ml heparin for 10 min. Cell lysis, immunoprecipitation
and Western analysis were performed as previously described (Burgar et al.,
2002). Membranes were incubated with; anti-Fc-HRPO conjugate (Pierce
Biotechnology, 1:10,000), anti-HA (CR-UK, 1:1000), anti-Flg and anti-Bek for
FGFR1 and FGFR2, respectively (Santa Cruz, 1:1000).
For analysis of gene expression, cells were not stimulated (0 min) or
stimulated with FGF2 (30/60 min) as described above and total RNA was
prepared using TRIZOL reagent (Gibco) according to the manufacturer's
instructions. RT-PCR was performed using the QIAGEN Onestep RT-PCR kit
on 2 μg of total RNA under the following conditions: one cycle of 30 min at
42°C, one cycle of 15 min at 95°C, followed by 30 cycles of 30 s at 94°C, 30 s at
55°C, and 1 min at 72°C. The primers used were: FLRT1, 5′-CCACACA-
CACCATTGGCTAC and 5′-GCATGAGGTGTCCACAGATG; FLRT2, 5′-
CTATCTGAACAACGGCAGCA and 5′-AATTGTCCGCCTTGATAACG;
FLRT3, 5′-TGCAGAAGCTGGCACTAAGA and 5′-CAATCGCAGCAG-
TAACCTGA; GAPDH, 5′-TGAAGGTCGGAGTCAACGGATTTGGT and
5′-CATGTGGGCCATGAGGTCCACCAC. Reaction products were resolved
on a 0.8% agarose gel.
Results
FLRT genes in the mouse
To analyse the role of the leucine rich repeat transmembrane
protein encoding FLRT family of genes during mouse
development we isolated murine cDNAs containing the entireFig. 2. Expression of FLRT3 during mouse development. In situ hybridisation of 8
riboprobe for FLRT3. i–iii are sections of the embryo in D with the approximate plane
ventral forebrain; mhb—midbrain/hindbrain boundary; fmb—forebrain/midbrain boopen reading frames of the three members of the family. The
complete FLRT1 coding sequence was contained in the IMAGE
clone 2236543 (accession number AY495668). The mouse
FLRT2 and FLRT3 open reading frames were isolated by RT-
PCR from 10.5 dpc mouse embryos (accession numbers
AY495669 and AY495670, respectively) using primers
designed to 5′ and 3′ EST sequence reads. Comparison of the
mouse FLRT sequences showed the conserved structure of this
family consisting of 10 extracellular leucine rich repeats
surrounded by C- and N-terminal cysteine flanking sequences,
a fibronectin domain, a transmembrane domain and a short
intracellular tail (Fig. 1). Comparison between mouse and
human FLRT sequences showed very high levels of amino acid
and DNA sequence conservation (Fig. 1C). Human and mouse
FLRT1 were 96% similar at the protein level, the FLRT2s 97%
similar and the FLRT3s 96% similar. The predicted short
intracellular tails showed regions of high conservation indicat-
ing they may contain functional elements (Fig. 1A).
FLRT genes exhibit a conserved genomic structure in which
the entire open reading frame and 3′UTR, as well as some 5′
UTR, are present in a single large exon with further small
upstream exons constituting the remaining 5′UTR. This
organisation has been seen for the genes encoding the
structurally similar NLRR family of proteins (Haines et al.,dpc (A, B), 9.5 dpc (C), 10.5 dpc (D) and 11 dpc (E) mouse embryos with a
s of section shown by yellow lines. s—somites; vfb—hypothalamic region of the
undary; aer—apical ectodermal ridge; gc—germ cells; hm—head mesoderm.
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(Milan et al., 2001). Analysis of the mouse, rat and human
genomes found no other genes exhibiting the FLRT protein
domain structure defining the FLRTs as a three member
mammalian gene family.
FLRT3 expression during development
To examine FLRT3 expression during mouse embryogenesis
we performed whole-mount in situ hybridisation on mouse
embryos from 8 to 11 dpc. Developmentally regulated
expression was seen in a variety of tissues. At 8 dpc expression
was seen in a distinct band in the developing brain (Fig. 2A,
arrowhead) and in the somites (Figs. 2A and B). At 9.5 dpcFig. 3. Expression of FLRT3 during somite development. Higher magnification of the
11 dpc (C and D) mouse embryos with a riboprobe for FLRT3. i–iii are sections of the
of section shown by yellow lines. aer—apical ectodermal ridge.neural expression could be seen in the midbrain at the
boundaries with the hindbrain and forebrain (Fig. 2C). This
expression was also evident at 10.5 dpc (Figs. 2D and Di) and
11 dpc (Fig. 2E), however, expression at the midbrain/hindbrain
boundary was less intense. Expression was seen at 9.5 dpc in the
developing eye, in the hypothalamic region in the ventral
forebrain, in the somites (Fig. 2C) and in the migrating
epithelial structure surrounding the lower region of the
developing heart (Fig. 2C, arrowhead). At 10.5 dpc, expression
was seen in the eye and the head mesoderm (Fig. 2Dii), in the
migrating epithelial structure surrounding the lower heart (Fig.
2D and Diii, arrowheads) and in the apical ectodermal ridge
(Fig. 2D). These sites of expression are consistent with FLRT3
expression in rat (Robinson et al., 2004). At 11 dpc expressiondeveloping somites from in situ hybridisations of 9.5 dpc (A), 10.5 dpc (B) and
embryo in panel B and iv of the embryo in panel C with the approximate planes
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migrating germ cells and the limb (Fig. 2E).
The pattern of expression of FLRT3 in the somites was
particularly striking (Figs. 2 and 3). Expression was seen at
8 dpc in the earliest forming somites at the dorsal lip with
expression extending ventrally along the rostral and caudal
lips (Fig. 2B). At 9.5 and 10.5 dpc, expression in the earliest
somites occurred throughout the inner edge of the somitic
epithelium but was stronger dorsally (Figs. 3A, B and Bi). In
slightly more mature somites, expression had decreased
throughout the epithelium and increased at the somitic lips
(Figs. 3A, B and Bii). As the somite expanded dorso-ventrally
expression was highest at the dorsal and ventral lips (Figs.
3A, B). At 9.5 dpc somites close to the limb bud showed
increased expression at the ventral lip with expression still
being present at lower levels at the dorsal lip (Fig. 3A). At
10.5 dpc, when the limb bud had formed and FLRT3
expression in the apical ectodermal ridge was apparent, strong
ventral expression in interlimb somites was clear (Fig. 3B and
Biii) with loss of this expression in limb level somites and
anterior trunk somites (Fig. 3B). At 11 dpc, there was strong
dermomyotomal and myotomal expression in the ventral lip atFig. 4. Expression of FLRT1 during mouse development. In situ hybridisation of 9.5 d
i–iii are sections of the embryo in panel B with the approximate planes of section
midbrain boundary; drg—dorsal root ganglia; fg—foregut; tg—trigeminal ganglia;the interlimb level (Fig. 3C and C iv) that was downregulated
adjacent to both limb buds (Figs. 2E and 3C). Tail expression
occurs from the dorsal somite lips and extended ventrally
along the anterior and posterior lips (Fig. 3D).
Expression of FLRT1 and 2 during mouse development
FLRT1 expression was analysed on mouse embryos from 9
to 11 dpc. Expression was initially seen at 9.5 dpc in the
midbrain in a strong stripe adjacent to the midbrain/hindbrain
boundary with lower level expression at the midbrain/forebrain
boundary (Fig. 4A). At 10.5 dpc, expression at the brain
boundaries was still evident (Fig. 4Bi) with additional
expression seen in the eye, an unidentified region in the
epithelium lining the foregut (Fig. 4Bii) and in the dorsal root
ganglia and the trigeminal ganglia (Fig. 4Biii). Transverse
sections through the torso at limb level revealed localised
expression in cells adjacent to the urogenital ridge (Fig. 4Biii,
arrowheads). At 11 dpc, expression continued in the dorsal root
ganglia and became apparent in the facio-acoustic ganglion.
Expression in the midbrain had tightly restricted to the
midbrain/hindbrain boundary and expression in the foregutpc (A), 10.5 dpc (B) and 11 dpc (C) mouse embryos with a riboprobe for FLRT1.
shown by yellow lines. mhb—midbrain/hindbrain boundary; fmb—forebrain/
fa—facio acoustic ganglia.
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posterior edge of the third branchial arch (Fig. 4C).
In situ hybridisation analysis of FLRT2 showed strong
expression at 9.5 dpc in the cephalic mesenchyme around the
ventral midbrain and strong expression in tissue posterior to the
developing heart (Fig. 5A). At 10.5 dpc, strong expression was
again seen in the cephalic mesenchyme adjacent to the ventral
neural vesicle (Fig. 5Bi), as well as in mesenchymal tissue in the
anterior trunk that crosses the embryo ventral to the neural tube
(Fig. 5Bii) and ventral head mesoderm adjacent to the forebrain
(Fig. 5B). Strong expression was seen posterior to the
developing heart in the body wall overlying the pericardial
cavity (Fig. 5Biii) and in the developing stomach (Fig. 5Biv). At
10.5 dpc, segmental stripes of expression were seen throughout
the trunk (Fig. 5B). Sections through this region showed that
this expression occurs in a group of cells that lie between theFig. 5. Expression of FLRT2 during mouse development. In situ hybridisation of 9.5 d
i–v are sections of the embryo in panel B with the approximate planes of section sh
mesenchyme; tm—trunk mesenchyme; scl—sclerotome; dm—dermomyotome, nt—dorsal root ganglia and the dermomyotomes of the somites (Fig.
5Biii and iv). Cross sections showed that these cells are in the
posterior half of the somite indicating that they are a subset of
the sclerotome (Fig. 5Bv). At 11 dpc further expression is clear
in the branchial arches, the eye and the limbs (Fig. 5C).
FLRT proteins
From their predicted secondary structure mouse FLRT pro-
teins are likely to be transmembrane proteins involved in cell
adhesion and/or signalling. To analyse the cellular localisation
of FLRT proteins expression constructs containing FLRT
cDNAs with a 5′ FLAG tag directly N-terminal of the N-
terminal cysteine flanking sequence were produced. When
overexpressed in Cos-7 cells, these proteins were efficiently
localised to the cell surface membranes as well as to perinuclearpc (A), 10.5 dpc (B) and 11 dpc (C) mouse embryos with a riboprobe for FLRT3.
own by yellow lines. The anterior (A) side of section v is shown. cm—cephalic
neural tube; bw—body wall; drg—dorsal root ganglia; st—stomach.
Fig. 6. FLRT proteins are glycosylated transmembrane proteins that form homophilic cell–cell contacts that colocalise with the focal adhesion marker vinculin.
Immunohistochemical staining of Cos-7 cells transfected with plasmids encoding 5′ FLAG-tagged FLRT1 (A, B), FLRT2 (C, D) and FLRT3 (E, F) proteins. Panels A,
C, E are fixed and permeabilised before staining. Panels B, D, F are fixed only to detect protein at the cell surface. (G, H) Immunohistochemical staining of live Cos-7
cells transfected with an expression construct for 5′ FLAG-tagged FLRT3. Panels G and H are views from the same transfection. Cells not in contact with another
FLRT3 overexpressing cell show uniform staining across the cell whereas cells adjacent to another overexpressing cell show accumulation of FLRT3 at cell–cell
contacts. (I–K) Confocal images of Cos-7 cells transfected with 5′ FLAG-tagged FLRT3 and stained with anti-FLAG antibody (red) and costained with an anti-
vinculin antibody (green). Panel K is a merged image of I and J showing colocalisation of FLRT3 and vinculin at the contacts between adjacent FLRT3 overexpressing
cells. A non-expressing cell is highlighted by the asterisk. (L) Western blot of cell extracts from Cos-7 cells transfected with expression constructs for 3′ HA-tagged
FLRT1, FLRT2 and FLRT3 proteins and incubated with (+) or without (−) tunicamycin. Size of protein molecular weight standards is shown. Control is cells
transfected with pCDNA3.1 expression vector.
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permeabilised cells showed that the predicted extracellular
domain containing the 5′ FLAG tag and leucine rich repeats was
expressed on the cell surface (Figs. 6B, D, F).
A member of the similar NLRR protein family has been
shown to be internalised by interaction via its intracellular
domain with clathrin adapters (Fukamachi et al., 2002). FLRT
proteins have a conserved intracellular sequence so to test if this
is involved in protein internalisation we analysed movement of
FLRT protein at the cell surface by incubating live cells
transfected with C-terminal FLAG tagged FLRT cDNAs with
anti-flag antibody. No vesicular internalisation of FLRT3 was
seen, however two different cellular stainings were observed
(Figs. 6G and H). Cells transfected with FLRT3 that were
isolated from other FLRT positive cells showed staining that
was uniformly spread throughout the cell membrane (Fig. 6G).
FLRT3 positive cells that were adjacent to other over expressing
cells showed an accumulation of protein staining at the cell–cell
junction (Fig. 6H), with the amount of protein accumulated at
the cell junctions correlating with a decrease in staining levels in
the rest of the membrane. FLRT3 protein localised to small cell
contacts where cell projections contacted adjacent cells (Fig.
6K, arrows) and also to extensive regions of contact showing a
large accumulation of FLRT protein (Fig. 6K, arrowhead).
Localisation of FLRT3 at cell contacts did not occur at the
junctions between FLRT3 transfected and untransfected cells
(Fig. 6K, asterisk). Identical protein localisations were seen in
FLRT1 and 2 transfected cells (data not shown). To determine
the properties of FLRT3 cell–cell contacts we co-stained cells
transfected with FLRT3 with an antibody against vinculin, a
marker for focal adhesions (Figs. 6, I–K). Confocal analysis
showed that vinculin protein localised to both large FLRT3Fig. 7. FLRTs interact with the FGF signalling pathway. (A) 293T cells were trans
immunoprecipitated (IP) and Western blotted (WB) with the appropriate antibodies.
cDNA and analysed by immunoprecipitation with anti-HA antibody and Western blo
blots using anti-FGFR1 and anti-HA antibodies showing the input samples are show
RNA subjected to semi-quantitative RT-PCR to examine FLRTexpression. Samples w
is shown as a control.contacts and small FLRT3 positive contacts made by cell
projections contacting an adjacent FLRT3 positive cell (Fig.
6K). Vinculin also colocalised with FLRT1 and 2 at cell
contacts (data not shown). These data indicate that when two
cells expressing FLRT protein are adjacent there is active
movement of these proteins to focal adhesion junctions
suggesting that a homophilic intercellular recognition occurs
through FLRT proteins.
To determine if FLRT proteins are glycosylated constructs
containing FLRT cDNAs with a C-terminal HA tag were
transfected into Cos-7 cells and resultant proteins analysed by
Western blot. For each FLRT construct a band of approximately
100 kDa was seen which was reduced in size to approximately
85 kDa, the size expected for full length FLRTs, by treatment
with the glycosylation inhibitor tunicamycin (Fig. 6G). An
additional band was present at approximately 20 kDa which
must be liberated from the C-terminus in accordance to the
location of the HA tag. The size of this band corresponds to the
predicted size of a protein produced by cleavage around the
transmembrane domain.
FLRTs interact with the FGF signalling pathway
In Xenopus, FLRT3 has been shown to interact with FGF
receptors 1 and 4 (Bottcher et al., 2004). The different mouse
FLRT transcripts are all expressed in some tissues where FGF
signalling is known to be important for their formation. To
determine if mouse FLRT proteins interact with FGFR1, 3′ HA
tagged FLRT cDNAs were cotransfected into 293T cells with a
FGFR1 fusion construct made constitutively active by fusion to
the immunoglubulin Fc domain (Burgar et al., 2002). This
construct was shown to interact with all three FLRT proteins,fected with 3′HA-tagged FLRT cDNAs and a FGFR1/Fc fusion construct and
(B) 293T cells were co-transfected with 3′HA-tagged FLRT cDNAs and FGFR1
tted with anti-FGFR1, with (+) or without (−) stimulation using FGF-2. Western
n. Control is untransfected cells. (C) 293T cells were stimulated with FGF-2 and
ere taken before stimulation (0) and after stimulation for 30 and 60 min. GAPDH
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FLRT1 and 2 (Fig. 7A). To examine if the interaction was
dependent on receptor activation we performed immunoprecip-
itation of cells cotransfected with FLRTs and full length
receptor before or after stimulation with FGF-2 (Fig. 7B). All
FLRTs interacted with full length FGFR1 in the presence and
absence of FGF-2 stimulation. The interaction with FLRT1 and
2 was stronger than with FLRT3, consistent with the data from
the FGFR fusion proteins. These data show that all members of
the FLRT family can interact with the FGF signalling pathway
and that there may be some specificity of interaction between
different FLRT members and different FGF receptors.
Bottcher et al. (2004) also showed that FLRT3 expression
can be induced by the activation of FGF signalling. To see if this
was also true of mouse FLRT genes we stimulated 293T cells
with FGF-2 and examined FLRT expression using semi-
quantitative RT-PCR. Before stimulation all FLRTs were
expressed in 293T cells consistent with expression of FLRTs
in kidney (Lacy et al., 1999, Supplementary Fig. 1). Upon
stimulation with FGF-2, expression of all FLRT genes was
induced after 30 min with the increased levels remaining after
60 min stimulation (Fig. 7C). These data show that expression
of all three mouse FLRT genes can be regulated by FGF
signalling.
Discussion
In this study, we have analysed the expression of the FLRT
gene family during mouse development. The three FLRT genes
encode a highly conserved family of glycosylated leucine rich
repeat containing membrane proteins that are expressed at the
cell surface. In the mouse there is an increasing number of
multi-member gene families that encode membrane proteins
with extracellular leucine rich repeats (Musacchio and Perri-
mon, 1996; Nagasawa et al., 1999; Lacy et al., 1999; Carim-
Todd et al., 2003; Kuja-Panula et al., 2003; Lauren et al., 2003;
Hamano et al., 2004; Haines et al., 2005). The functions of these
genes are generally not known, however, many of the proteins
are expressed in the nervous system and several, including
FLRT3, have been suggested to play roles in neurite outgrowth,
axon guidance and synapse formation with some thought to act
homophilically (Nose et al., 1997; Shishido et al., 1998;
Fournier et al., 2001; Kuja-Panula et al., 2003; Robinson et al.,
2004).
FLRT3 shows a provocative expression pattern in the
somites. In the early somites, expression occurs at the dorsal
somitic lip on the inner edge of the dermomyotome. As the
somite develops expression restricts to the dorsal and ventral
lips. At the interlimb level, expression is stronger at the ventral
lip with somites anterior to the forelimb showing little or no
expression in the ventral lip. This expression corresponds in
position and intensity to the regions of the somite where muscle
precursor cells migrate from the dermomyotome and move into
the myotome, or out of the myotome towards their final
destination. For example, expression in the ventral lip of the
earliest somites corresponds with the initial migration of
myoblasts from this region into the myotome (Kalcheim etal., 1999). Later expression in both lips corresponds to myoblast
migration from both dorsal and ventral lips in the later phase of
myotome development (Ordahl et al., 2000). Strong expression
of FLRT at the ventral lip of interlimb level somites corresponds
with the increased migration of myoblasts associated with the
formation of the trunk muscles with lack of ventral expression
in limb level somites corresponding to the absence of a ventral
lip. This transition involves a marked change from the epithelial
morphology of the dermomyotome to the less adhesive
myoblast morphology and may in part be regulated by the
expression of FLRT3 at the cell surface.
Xenopus FLRT3 (XFLRT3) was identified as a gene with a
similar expression pattern to FGF signalling molecules,
particularly at the midbrain/hindbrain boundary (Bottcher et
al., 2004). It was shown to be regulated by FGF signalling, be
able to modulate FGF signalling and to interact with the FGF
receptor. Our analysis in the mouse shows FLRT expression in
regions known to express FGF signalling components and in
regions known to be affected by FGF signalling. Expression of
FLRT1 and 3 at the midbrain/hindbrain boundary correlates
with FGF expression and the role of FGFs in formation of and
signalling from the isthmus (Carl andWittbrodt, 1999; Trokovic
et al., 2003). Expression of FLRT3 in the apical ectodermal
ridge co-localises with FGF expression here and the known role
of FGFs in limb formation (Lewandoski et al., 2000).
Expression of FLRT3 in the somites also correlates with
known sites of expression and roles for FGF signalling
components (Kahane et al., 2001; Brent et al., 2003).
Expression of FLRT2 in a sub-domain of the sclerotome
could provide a mechanism for regulated expression of scleraxis
by FGF signalling pathways in the domain of the somitic tendon
progenitors (Brent and Tabin, 2004). Roles for FGF signalling
have been suggested in dorsal root ganglia (Tanaka et al., 2001;
Li et al., 2002), various aspects of eye development (Vogel-
Hopker et al., 2000; Faber et al., 2001; Webber et al., 2003) and
the cephalic mesenchyme (Mayordomo and Alvarez, 2000), all
tissues that express FLRTs. We have shown that, consistent with
their expression patterns, all three mammalian FLRTs can
interact with FGF receptor 1 suggesting that a role in the
regulation of the FGF signalling pathway may be a generic
feature of the FLRT family. Furthermore, expression of all three
FLRTs can be induced by the activation of FGF signalling
suggesting that they may act on the FGF receptor in a feedback
mechanism.
We have shown that all three mouse FLRTs can interact with
FGFR1, in a fashion that is independent of receptor activation,
and Bottcher et al. (2004) showed that XFLRT3 can interact
with both FGFR1 and R4. Our data indicate that there is some
specificity to these interactions, as FLRT3 binds less well to
FGFR1 than do the other two family members, suggesting that
the various FLRTs may interact with different FGFR signalling
pathways. This suggestion is supported by consideration of the
available expression data. For example, FLRT1 interacts
strongly with FGFR1, and both are expressed in the dorsal
root ganglia (Oellig et al., 1995) while FLRT2, which shows the
strongest binding to FGFR1, is co-expressed with this receptor
in mesenchyme tissue (Peters et al., 1992) and in the sclerotome
24 B.P. Haines et al. / Developmental Biology 297 (2006) 14–25(Brent and Tabin, 2004). Regulation of FGFR1 by FLRT2,
which is expressed in a subset of the sclerotome, may explain
why FGF-dependent scleraxis expression is confined to the
syndetome (Brent and Tabin, 2004) despite the much broader
expression of FGFR1. Interestingly, FLRTs interacted with a
constitutively active FGFR1 containing only the transmem-
brane and intracellular domains fused to immunoglobulin Fc
(Burgar et al., 2002). This seems inconsistent with XFLRT3
interaction with both FGFRs through the fibronectin domain
(Bottcher et al., 2004). However, a construct of XFLRT3
containing only the transmembrane and intracellular domains
was active in inducing ectopic tails in Xenopus and could
interact to some extent with FGFRs (Bottcher et al., 2004).
Furthermore, a decrease in interaction was observed between
FGFRs and XFLRT3 lacking a transmembrane domain
(Bottcher et al., 2004) suggesting that interaction may not be
restricted to the fibronectin domain. The details of how each
FLRT interacts with and affects each FGF signalling pathway
remain to be elucidated but their interaction and co-expression
suggests that FLRTs play important roles in these pathways.
Many leucine rich repeat transmembrane proteins have been
predicted to function in the nervous system with several
effecting axon guidance or synapse formation (Nose et al.,
1997; Shishido et al., 1998; Fournier et al., 2001; Kuja-Panula
et al., 2003; Robinson et al., 2004). The widespread expression
of FLRT family members during mouse development and their
interaction with FGF signalling suggests a more fundamental
role. All three members of the FLRT gene family show
developmentally restricted expression patterns with each FLRT
gene exhibiting a distinct expression profile from the other
family members. Expression of different FLRT genes occurs in
groups of cells that are distinct from the surrounding cell
populations. For example, FLRT1 expression in the dorsal root
ganglia, FLRT2 expression in a subset of sclerotome cells and
FLRT3 expression in the apical ectodermal ridge. The
interaction of all FLRT molecules with FGF receptors suggests
that FGF signalling may be important in the formation of all
these tissues and regulation by FLRT may provide some
specificity to the complex FGF signalling environment in the
embryo. The observed increase in neurite outgrowth of cells
overexpressing rat FLRT3 (Tsuji et al., 2004) could be
explained by altered FGF signalling, with FGF-2 known to
mediate neurite outgrowth in culture (Kim et al., 2003).
When overexpressed in Cos cells FLRTs were efficiently
expressed at the cell surface and localised to cell–cell contacts
in a homophilic manner. Previous studies using overexpression
of FLRT3 in non-adhesive cells have shown that FLRT3 cannot
mediate homophilic cell adhesion (Tsuji et al., 2004; Robinson
et al., 2005). Our data suggest that FLRTs can mediate a
homophilic intercellular recognition even though it may not be
sufficient to confer adhesion. This is supported by Karaulanov
et al. (2006) who showed that FLRTs can mediate homotypic
cell sorting in 293T cells and Xenopus embryos. Some leucine
rich repeat proteins with similar secondary structures to FLRTs
have been shown to mediate homophilic cell adhesion (Nose et
al., 1997; Kuja-Panula et al., 2003) but others do not (Hayata et
al., 1998; Shishido et al., 1998; Tsuji et al., 2004). Thecolocalisation of FLRTs to cell–cell contacts with the
cytoskeletal attachment protein vinculin identifies them as
focal adhesions. The details of the interactions between FGF
signalling, FLRTs and focal adhesions still remain to be
elucidated, however, it points further to FLRTs role in the
regulation of signalling with FGFR1 shown to localise to cell
adhesion contacts (Tanghetti et al., 2002).
Other leucine rich repeat transmembrane proteins from
different families have also been implicated in the regulation of
cell signalling. The vasorin protein has been shown to interact
with the TGF-β ligand and regulate the cellular response to
TGF-β (Ikeda et al., 2004). Kekkon 1 can inhibit EGF receptor
activity (Ghiglione et al., 2003) and rat NLRR-3 may be
involved in the regulation of EGF receptor signalling through an
intracellular clathrin adapter interaction motif (Fukamachi et al.,
2002). These data suggest that roles for leucine rich repeat
transmembrane proteins in cell signalling may be widespread.
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